Press Releases

Achieve Life Sciences

January 5th 2017: Achieve Life Sciences, Inc. and OncoGenex Pharmaceuticals, Inc. Announce Definitive Merger Agreement

January 9th 2012: Tabex shown to be a highly cost effective treatment for smoking cessation - study published in peer reviewed journal, Nicotine and Tobacco Research

September 29th 2011: Achieve Life Sciences announces TASC ("TAbex Smoking Cessation") pivotal trial meets all primary and secondary endpoints with statistically significant quit rates at 1 year

March 8th 2017: Achieve Life Sciences and OncoGenex Announce Cytisine Symposium at the Annual Society for Research on Nicotine and Tobacco Conference

March 1st 2017: Achieve Life Sciences and OncoGenex Pharmaceuticals Announce Strategic Collaboration with the National Institutes of Health to Advance the Development of Cytisine for Smoking Cessation

Renown Pharma

March 7th 2017: Renown Pharma Announces Successful Results of Apomorphine Sub-lingual Spray Pharmacokinetic Study to Treat "OFF" Episodes in Parkinson's Disease Patients